{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T09:12:38Z","timestamp":1764493958104,"version":"3.41.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.saa.2017.07.021","type":"journal-article","created":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T17:02:10Z","timestamp":1500310930000},"page":"318-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["An innovative validated spectrofluorimetric method for determination of Lisinopril in presence of hydrochlorothiazide; application to content uniformity testing"],"prefix":"10.1016","volume":"188","author":[{"given":"Sayed M.","family":"Derayea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid M.","family":"Badr El-din","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma F.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2006","series-title":"Goodman & Gilman's the Pharmacological Basis of Therapeutics","author":"Laurence","key":"10.1016\/j.saa.2017.07.021_bb0005"},{"key":"10.1016\/j.saa.2017.07.021_bb0010","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0731-7085(01)00382-X","article-title":"Spectrophotometric and HPTLC-densitometric determination of lisinopril and hydrochlorothiazide in binary mixtures","volume":"25","author":"El-Gindy","year":"2001","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2017.07.021_bb0015","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0731-7085(02)00654-4","article-title":"Spectrophotometric and polarographic determination of enalapril and lisinopril using 2,4-dinitrofluorobenzen","volume":"31","author":"Abdel Razaka","year":"2003","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2017.07.021_bb0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.japna.2003.08.021","article-title":"Determination of lisinopril in dosage forms and spiked human plasma through derivatization with 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) followed by spectrophotometry or HPLC with fluorimetric detection","volume":"34","author":"El-Emam","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2017.07.021_bb0025","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0731-7085(02)00207-8","article-title":"Spectrophotometric determination of lisinopril in tablets using 1-fluoro-2,4-dinitrobenzene reagent","volume":"29","author":"Atta-Politou","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2017.07.021_bb0030","series-title":"Modern Chemistry & Applications","article-title":"Analytical determination of lisinopril using UV spectrophotometer and HPLC: an overview","volume":"02","author":"Naveed","year":"2014"},{"key":"10.1016\/j.saa.2017.07.021_bb0035","first-page":"185","article-title":"Spectrophotometric determination of Lisinopril dosage form by condensation reaction","volume":"3","author":"Jamakhandi","year":"2011","journal-title":"Int J Pharm Pharm Sci"},{"key":"10.1016\/j.saa.2017.07.021_bb0040","first-page":"106","article-title":"A new spectrophotometric method for the determination of cardiovascular drugs in dosage forms","volume":"5","author":"Ali","year":"2013","journal-title":"Am. Acad. Scholarly Res. J."},{"key":"10.1016\/j.saa.2017.07.021_bb0045","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0731-7085(97)00075-7","article-title":"Analysis of ACE inhibitors in pharmaceutical dosage forms by derivative UV spectroscopy and liquid chromatography (HPLC)","volume":"16","author":"Bonazzi","year":"1997","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2017.07.021_bb0050","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0731-7085(98)00110-1","article-title":"Spectrophotometric and spectrofluorometric methods for the assay of lisinopril in single and multicomponent pharmaceutical dosage forms","volume":"19","author":"Abdine","year":"1999","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2017.07.021_bb0055","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0731-7085(01)00376-4","article-title":"Spectrophotometric, septrofluorimetric and LC determination of lisinopril","volume":"25","author":"El-Gindy","year":"2001","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2017.07.021_bb0060","first-page":"209","article-title":"New fluorimetric method development for Lisinopril by condensation reaction","volume":"2","author":"Jamakhandi","year":"2010","journal-title":"Int J Pharm Pharm Sci"},{"key":"10.1016\/j.saa.2017.07.021_bb0065","doi-asserted-by":"crossref","first-page":"182","DOI":"10.25004\/IJPSDR.2010.020304","article-title":"New fluorimetric method of determination for lisinopril dosage forms","volume":"2","author":"Jamakhandi","year":"2010","journal-title":"Int. J. Pharm. Sci. Drug Res."},{"key":"10.1016\/j.saa.2017.07.021_bb0070","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0014-827X(02)00013-7","article-title":"A new spectrofluorimetric method for the determination of lisinopril in tablets","volume":"58","author":"Aktas","year":"2003","journal-title":"IL Farmaco"},{"key":"10.1016\/j.saa.2017.07.021_bb0075","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00216-004-2530-4","article-title":"Rapid spectrofluorimetric determination of lisinopril in pharmaceutical tablets using sequential injection analysis","volume":"379","author":"Zacharis","year":"2004","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.saa.2017.07.021_bb0080","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jchromb.2004.06.021","article-title":"Lisinopril quantification in human plasma by liquid chromatography\u2013electrospray tandem mass spectrometry","volume":"809","author":"Astigarraga","year":"2004","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.saa.2017.07.021_bb0085","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jpba.2004.11.021","article-title":"Development and validation of a stability indicating HPLC method for determination of lisinopril, lisinopril degradation product and parabens in the lisinopril extemporaneous formulation","volume":"37","author":"Beasley","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2017.07.021_bb0090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.aca.2005.07.006","article-title":"Development of a rapid liquid chromatography tandem mass spectrometry method for the determination of lisinopril, applicable for a bioequivalence study, employing a 96-well format solid phase extraction protocol","volume":"551","author":"Kousoulos","year":"2005","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.saa.2017.07.021_bb0095","first-page":"1","article-title":"HPLC-PDA analysis of ACE-inhibitors,hydrochlorothiazide and indapamide utilizing design of experiments","author":"Dawud","year":"2014","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.saa.2017.07.021_bb0100","first-page":"226","article-title":"Simple and stability indicating RP-HPLC assay method development and validation lisinopril dihydrate by RP-HPLC in bulk and dosage form","volume":"3","author":"Babu","year":"2015","journal-title":"Int. J. Curr. Res. Acad. Rev."},{"key":"10.1016\/j.saa.2017.07.021_bb0105","first-page":"635","article-title":"Validated RP-HPLC method for simultaneous estimation of lisinopril and hydrochlorothiazide in combined dosage forms","volume":"2","author":"Nagaraju","year":"2014","journal-title":"Int. J. Chem. Pharm. Sci."},{"key":"10.1016\/j.saa.2017.07.021_bb0110","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0165-022X(02)00140-9","article-title":"Reversed-phase liquid chromatography of lisinopril conformers","volume":"54","author":"Bouabdallaha","year":"2002","journal-title":"J. Biochem. Biophys. Methods"},{"key":"10.1016\/j.saa.2017.07.021_bb0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jchromb.2004.06.014","article-title":"An HPLC method for the determination of lisinopril in human plasma and urine with fluorescence detection","volume":"809","author":"Sagirli","year":"2004","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.saa.2017.07.021_bb0120","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/0378-4347(95)00268-4","article-title":"Determination of the angiotensin-converting enzyme inhibitor lisinopril in urine using solid-phase extraction and reversed phase high-performance liquid chromatography","volume":"673","author":"Wong","year":"1995","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.saa.2017.07.021_bb0125","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cclet.2011.11.024","article-title":"Determination of lisinopril using anion exchange chromatography with integrated pulsed amperometric detection","volume":"23","author":"Liu","year":"2012","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.saa.2017.07.021_bb0130","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0731-7085(00)00240-5","article-title":"Analysis of ACE-inhibitors by CE using alkylsulfonic additives","volume":"22","author":"Gotti","year":"2000","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2017.07.021_bb0135","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0021-9673(01)00714-2","article-title":"Simultaneous determination of hydrochlorothiazide and several inhibitors of angiotensin-converting enzyme by capillary electrophoresis","volume":"924","author":"Hillaert","year":"2001","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.saa.2017.07.021_bb0140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0021-9673(00)00591-4","article-title":"Optimization of capillary electrophoretic separation of several inhibitors of the angiotensin-converting enzyme","volume":"895","author":"Hillaert","year":"2000","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.saa.2017.07.021_bb0145","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0731-7085(01)00366-1","article-title":"The quantitative determination of several inhibitors of the angiotensin-converting enzyme by CE","volume":"25","author":"Hillaert","year":"2001","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2017.07.021_bb0150","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0731-7085(95)01718-6","article-title":"Time-resolved fluoroimmunoassay for the determination of lisinopril and enalaprilat in human serum","volume":"14","author":"Yuan","year":"1996","journal-title":"J. Pharm. Biomed. Anal."},{"year":"1974","series-title":"Colorimetric and Fluorimetric Analysis of Organic Componds and Drugs","author":"Pesez","key":"10.1016\/j.saa.2017.07.021_bb0155"},{"year":"2007","series-title":"The United States Pharmacopoeia 30, the National Formulary 25 US Pharmacopeial Convention, Electronic Version","author":"Rockville","key":"10.1016\/j.saa.2017.07.021_bb0160"},{"key":"10.1016\/j.saa.2017.07.021_bb0165","doi-asserted-by":"crossref","first-page":"9763","DOI":"10.1039\/c2ra21406g","article-title":"Recent advances in new multicomponent synthesis of structurally diversified 1, 4-dihydropyridines","volume":"2","author":"Wan","year":"2012","journal-title":"RSC Adv."},{"key":"10.1016\/j.saa.2017.07.021_bb0170","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1021\/jo01302a020","article-title":"The hantzsch 1, 4-dihydropyridine synthesis as a route to bridged pyridine and dihydropyridine crown ethers","volume":"45","author":"Kellogg","year":"1980","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.saa.2017.07.021_bb0175","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/anie.198107621","article-title":"4-Aryldihydropyridines, a new class of highly active calcium antagonists","volume":"20","author":"Bossert","year":"1981","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.saa.2017.07.021_bb0180","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2478\/s11532-008-0011-x","article-title":"Spectrofluorometric determination of nicardipine, nifedipine and isradipine in pharmaceutical preparations and biological fluids","volume":"6","author":"Al-Ghannam","year":"2008","journal-title":"Open Chem."},{"key":"10.1016\/j.saa.2017.07.021_bb0185","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1248\/cpb.35.4656","article-title":"Fluorescence of 1, 4-dihydropyridine derivatives relevant to age pigments","volume":"35","author":"Kikugaw","year":"1987","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.saa.2017.07.021_bb0190","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1562\/2006-05-22-RA-898","article-title":"Photophysics and photochemical studies of 1, 4-dihydropyridine derivatives","volume":"83","author":"P\u00e1vez","year":"2007","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.saa.2017.07.021_bb0195","first-page":"2732","article-title":"Spectrofluorimetric method of analysis for gabapentin in spiked human plasma and formulations","volume":"5","author":"Prasad","year":"2013","journal-title":"Int. J. ChemTech Res."},{"key":"10.1016\/j.saa.2017.07.021_bb0200","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1134\/S1061934814070065","article-title":"Spectrofluorimetric determination of cephradine in commercial formulation using ethylacetoacetate-formaldehyde as fluorogenic agent","volume":"69","author":"Shah","year":"2014","journal-title":"J. Anal. Chem."},{"key":"10.1016\/j.saa.2017.07.021_bb0205","doi-asserted-by":"crossref","first-page":"27735","DOI":"10.1039\/C4RA16650G","article-title":"Development and validation of a stability-indicating spectrofluorimetric method for the determination of H1N1 antiviral drug (oseltamivir phosphate) in human plasma through the Hantzsch reaction","volume":"5","author":"Omar","year":"2015","journal-title":"RSC Adv."},{"year":"1996","series-title":"Validation of Analytical Procedures: Methodology International Conference on Harmonization (ICH) of Technical Requirements for the Registration Pharmaceuticals for Human Use in, Geneva","key":"10.1016\/j.saa.2017.07.021_bb0210"},{"key":"10.1016\/j.saa.2017.07.021_bb0215","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1021\/ac50030a047","article-title":"Corrections for inner-filter effects in fluorescence quenching measurements via right-angle and front-surface illumination","volume":"50","author":"Leese","year":"1978","journal-title":"Anal. Chem."},{"key":"10.1016\/j.saa.2017.07.021_bb0220","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00321578","article-title":"Assessment of inner filter effect corrections in fluorimetry","volume":"340","author":"Puchalski","year":"1991","journal-title":"Fresenius J. Anal. Chem."}],"container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142517305802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142517305802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T02:52:31Z","timestamp":1750647151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386142517305802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":44,"alternative-id":["S1386142517305802"],"URL":"https:\/\/doi.org\/10.1016\/j.saa.2017.07.021","relation":{},"ISSN":["1386-1425"],"issn-type":[{"type":"print","value":"1386-1425"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An innovative validated spectrofluorimetric method for determination of Lisinopril in presence of hydrochlorothiazide; application to content uniformity testing","name":"articletitle","label":"Article Title"},{"value":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.saa.2017.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}